103 Carnegie Center
Suite 100
Large and small device companies alike are flocking to the large, undermet opportunity of mitral valve regurgitation. Most are focused on techniques for repairing damaged valves. Endovalve Inc. is the first to attempt to commercialize a percutaneous approach to replacing damaged mitral valves.
103 Carnegie Center
Suite 100